Annual EBITDA
-$26.67 M
-$12.70 M-90.87%
01 December 2023
Summary:
GeoVax Labs annual earnings before interest, taxes, depreciation & amortization is currently -$26.67 million, with the most recent change of -$12.70 million (-90.87%) on 01 December 2023. During the last 3 years, it has fallen by -$23.87 million (-854.20%). GOVX annual EBITDA is now -1719.14% below its all-time high of $1.65 million, reached on 31 December 2001.GOVX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.77 M
-$738.00 K-14.66%
01 September 2024
Summary:
GeoVax Labs quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.77 million, with the most recent change of -$738.00 thousand (-14.66%) on 01 September 2024. Over the past year, it has increased by +$2.62 million (+31.23%). GOVX quarterly EBITDA is now -205.38% below its all-time high of $5.48 million, reached on 31 December 2000.GOVX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$25.01 M
+$2.62 M+9.48%
01 September 2024
Summary:
GeoVax Labs TTM earnings before interest, taxes, depreciation & amortization is currently -$25.01 million, with the most recent change of +$2.62 million (+9.48%) on 01 September 2024. Over the past year, it has dropped by -$1.09 million (-4.54%). GOVX TTM EBITDA is now -1244.85% below its all-time high of $2.18 million, reached on 30 September 2001.GOVX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GOVX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.9% | +31.2% | -4.5% |
| 3 y3 years | -854.2% | -197.2% | -308.8% |
| 5 y5 years | -950.9% | -1269.2% | -942.5% |
GOVX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -854.2% | at low | -197.2% | +58.0% | -308.8% | +12.3% |
| 5 y | 5 years | -1031.1% | at low | -1269.2% | +58.0% | -1123.9% | +12.3% |
| alltime | all time | -1719.1% | at low | -205.4% | +58.0% | -1244.8% | +12.3% |
GeoVax Labs EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.77 M(+14.7%) | -$25.01 M(-9.5%) |
| June 2024 | - | -$5.03 M(-14.2%) | -$27.63 M(-3.1%) |
| Mar 2024 | - | -$5.86 M(-29.7%) | -$28.51 M(+6.0%) |
| Dec 2023 | -$26.67 M(+90.9%) | -$8.35 M(-0.5%) | -$26.90 M(+12.4%) |
| Sept 2023 | - | -$8.39 M(+42.0%) | -$23.93 M(+22.8%) |
| June 2023 | - | -$5.91 M(+39.0%) | -$19.49 M(+23.3%) |
| Mar 2023 | - | -$4.25 M(-20.8%) | -$15.81 M(+13.2%) |
| Dec 2022 | -$13.97 M(-24.6%) | -$5.37 M(+35.9%) | -$13.97 M(-37.4%) |
| Sept 2022 | - | -$3.95 M(+77.2%) | -$22.33 M(+9.9%) |
| June 2022 | - | -$2.23 M(-7.7%) | -$20.32 M(+4.8%) |
| Mar 2022 | - | -$2.42 M(-82.4%) | -$19.39 M(+4.6%) |
| Dec 2021 | -$18.53 M(+563.0%) | -$13.73 M(+607.2%) | -$18.53 M(+202.9%) |
| Sept 2021 | - | -$1.94 M(+49.3%) | -$6.12 M(+32.6%) |
| June 2021 | - | -$1.30 M(-16.5%) | -$4.61 M(+22.9%) |
| Mar 2021 | - | -$1.56 M(+18.1%) | -$3.75 M(+34.5%) |
| Dec 2020 | -$2.79 M(+18.5%) | -$1.32 M(+202.4%) | -$2.79 M(+35.6%) |
| Sept 2020 | - | -$436.20 K(-1.3%) | -$2.06 M(+0.7%) |
| June 2020 | - | -$442.00 K(-25.5%) | -$2.04 M(-9.3%) |
| Mar 2020 | - | -$593.60 K(+1.2%) | -$2.25 M(-4.4%) |
| Dec 2019 | -$2.36 M(-7.1%) | -$586.70 K(+39.2%) | -$2.36 M(-1.7%) |
| Sept 2019 | - | -$421.50 K(-35.3%) | -$2.40 M(-9.1%) |
| June 2019 | - | -$651.20 K(-6.8%) | -$2.64 M(+0.8%) |
| Mar 2019 | - | -$698.40 K(+11.2%) | -$2.62 M(+3.2%) |
| Dec 2018 | -$2.54 M(+18.5%) | -$628.30 K(-5.0%) | -$2.54 M(+4.9%) |
| Sept 2018 | - | -$661.30 K(+4.7%) | -$2.42 M(+3.4%) |
| June 2018 | - | -$631.50 K(+2.4%) | -$2.34 M(+5.5%) |
| Mar 2018 | - | -$616.60 K(+21.2%) | -$2.22 M(+3.5%) |
| Dec 2017 | -$2.14 M(-33.9%) | -$508.90 K(-12.5%) | -$2.14 M(-16.3%) |
| Sept 2017 | - | -$581.90 K(+14.1%) | -$2.56 M(+5.1%) |
| June 2017 | - | -$510.00 K(-5.8%) | -$2.44 M(-2.4%) |
| Mar 2017 | - | -$541.40 K(-41.6%) | -$2.49 M(-23.1%) |
| Dec 2016 | -$3.24 M(+21.6%) | -$926.90 K(+102.7%) | -$3.24 M(+8.0%) |
| Sept 2016 | - | -$457.30 K(-19.6%) | -$3.00 M(-5.0%) |
| June 2016 | - | -$568.90 K(-55.9%) | -$3.16 M(-3.1%) |
| Mar 2016 | - | -$1.29 M(+87.9%) | -$3.26 M(+22.3%) |
| Dec 2015 | -$2.67 M(-0.1%) | -$686.50 K(+11.8%) | -$2.67 M(-7.6%) |
| Sept 2015 | - | -$614.10 K(-8.5%) | -$2.88 M(+4.2%) |
| June 2015 | - | -$670.80 K(-3.4%) | -$2.77 M(+0.2%) |
| Mar 2015 | - | -$694.40 K(-23.3%) | -$2.76 M(+3.5%) |
| Dec 2014 | -$2.67 M(+20.7%) | -$905.40 K(+81.8%) | -$2.67 M(+2.3%) |
| Sept 2014 | - | -$498.00 K(-25.0%) | -$2.61 M(+14.2%) |
| June 2014 | - | -$664.30 K(+10.6%) | -$2.29 M(+7.2%) |
| Mar 2014 | - | -$600.90 K(-29.0%) | -$2.13 M(-3.5%) |
| Dec 2013 | -$2.21 M(+8.1%) | -$846.60 K(+387.1%) | -$2.21 M(+13.3%) |
| Sept 2013 | - | -$173.80 K(-65.9%) | -$1.95 M(-4.9%) |
| June 2013 | - | -$509.90 K(-24.9%) | -$2.05 M(+1.8%) |
| Mar 2013 | - | -$679.20 K(+15.6%) | -$2.02 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | -$2.05 M(-8.6%) | -$587.60 K(+114.1%) | -$2.04 M(-20.8%) |
| Sept 2012 | - | -$274.40 K(-42.2%) | -$2.58 M(-2.8%) |
| June 2012 | - | -$474.40 K(-32.9%) | -$2.65 M(+12.3%) |
| Mar 2012 | - | -$707.10 K(-37.1%) | -$2.36 M(+5.7%) |
| Dec 2011 | -$2.24 M(-14.8%) | -$1.12 M(+221.8%) | -$2.24 M(+43.5%) |
| Sept 2011 | - | -$349.20 K(+89.1%) | -$1.56 M(-14.5%) |
| June 2011 | - | -$184.70 K(-68.2%) | -$1.82 M(-28.3%) |
| Mar 2011 | - | -$580.20 K(+30.3%) | -$2.54 M(-3.2%) |
| Dec 2010 | -$2.63 M(-18.5%) | -$445.30 K(-27.4%) | -$2.63 M(-12.5%) |
| Sept 2010 | - | -$613.60 K(-32.2%) | -$3.00 M(+15.4%) |
| June 2010 | - | -$904.90 K(+36.3%) | -$2.60 M(-14.3%) |
| Mar 2010 | - | -$663.70 K(-19.0%) | -$3.04 M(-5.9%) |
| Dec 2009 | -$3.23 M(-13.8%) | -$819.40 K(+283.6%) | -$3.23 M(-6.1%) |
| Sept 2009 | - | -$213.60 K(-84.0%) | -$3.44 M(-13.0%) |
| June 2009 | - | -$1.34 M(+56.9%) | -$3.95 M(+1.3%) |
| Mar 2009 | - | -$853.60 K(-17.1%) | -$3.90 M(+4.2%) |
| Dec 2008 | -$3.74 M(-12.0%) | -$1.03 M(+41.8%) | -$3.74 M(-3.2%) |
| Sept 2008 | - | -$726.20 K(-43.6%) | -$3.86 M(-10.1%) |
| June 2008 | - | -$1.29 M(+85.0%) | -$4.30 M(-1.1%) |
| Mar 2008 | - | -$696.40 K(-39.6%) | -$4.35 M(+2.3%) |
| Dec 2007 | -$4.25 M(+599.9%) | -$1.15 M(-0.7%) | -$4.25 M(+30.0%) |
| Sept 2007 | - | -$1.16 M(-13.2%) | -$3.27 M(+35.8%) |
| June 2007 | - | -$1.34 M(+123.8%) | -$2.41 M(+174.5%) |
| Mar 2007 | - | -$597.80 K(+248.8%) | -$876.40 K(+39.2%) |
| Dec 2006 | -$607.20 K(-61.8%) | -$171.40 K(-42.6%) | -$629.70 K(+37.4%) |
| Sept 2006 | - | -$298.80 K(-255.9%) | -$458.30 K(+187.3%) |
| June 2006 | - | $191.60 K(-154.6%) | -$159.50 K(-54.6%) |
| Mar 2006 | - | -$351.10 K(-108.2%) | -$351.10 K(-175.6%) |
| Dec 2005 | -$1.59 M(-32.6%) | - | - |
| Dec 2004 | -$2.36 M(+1395.5%) | - | - |
| Dec 2003 | -$157.50 K(-187.4%) | - | - |
| Dec 2002 | $180.20 K(-89.1%) | $4.26 M(-513.5%) | $464.20 K(-59.2%) |
| Sept 2002 | - | -$1.03 M(-11.6%) | $1.14 M(+5.8%) |
| June 2002 | - | -$1.17 M(-27.2%) | $1.08 M(+40.1%) |
| Mar 2002 | - | -$1.60 M(-132.4%) | $768.00 K(-53.4%) |
| Dec 2001 | $1.65 M(+84.8%) | $4.94 M(-551.7%) | $1.65 M(-24.6%) |
| Sept 2001 | - | -$1.09 M(-25.9%) | $2.18 M(+225.8%) |
| June 2001 | - | -$1.47 M(+103.9%) | $670.70 K(-33.4%) |
| Mar 2001 | - | -$723.30 K(-113.2%) | $1.01 M(+138.0%) |
| Dec 2000 | $891.30 K(-114.5%) | $5.48 M(-310.0%) | $423.00 K(-108.4%) |
| Sept 2000 | - | -$2.61 M(+129.0%) | -$5.05 M(+106.6%) |
| June 2000 | - | -$1.14 M(-12.9%) | -$2.45 M(+87.1%) |
| Mar 2000 | - | -$1.31 M | -$1.31 M |
| Dec 1999 | -$6.14 M(+24.7%) | - | - |
| Dec 1998 | -$4.92 M(+28.4%) | - | - |
| Dec 1997 | -$3.83 M(+210.3%) | - | - |
| Dec 1996 | -$1.24 M | - | - |
FAQ
- What is GeoVax Labs annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for GeoVax Labs?
- What is GeoVax Labs annual EBITDA year-on-year change?
- What is GeoVax Labs quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for GeoVax Labs?
- What is GeoVax Labs quarterly EBITDA year-on-year change?
- What is GeoVax Labs TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for GeoVax Labs?
- What is GeoVax Labs TTM EBITDA year-on-year change?
What is GeoVax Labs annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GOVX is -$26.67 M
What is the all time high annual EBITDA for GeoVax Labs?
GeoVax Labs all-time high annual earnings before interest, taxes, depreciation & amortization is $1.65 M
What is GeoVax Labs annual EBITDA year-on-year change?
Over the past year, GOVX annual earnings before interest, taxes, depreciation & amortization has changed by -$12.70 M (-90.87%)
What is GeoVax Labs quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GOVX is -$5.77 M
What is the all time high quarterly EBITDA for GeoVax Labs?
GeoVax Labs all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.48 M
What is GeoVax Labs quarterly EBITDA year-on-year change?
Over the past year, GOVX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.62 M (+31.23%)
What is GeoVax Labs TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GOVX is -$25.01 M
What is the all time high TTM EBITDA for GeoVax Labs?
GeoVax Labs all-time high TTM earnings before interest, taxes, depreciation & amortization is $2.18 M
What is GeoVax Labs TTM EBITDA year-on-year change?
Over the past year, GOVX TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.09 M (-4.54%)